Florida Biologix
Florida Biologix, headquartered in Alachua, FL, is a preclinical and early clinical biologics contract development, manufacturing, and testing organization. Established in 2006 as part of the University of Florida's Center of Excellence for Regenerative Health Biotechnology, the company focuses on a wide range of value-optimizing services, including cell line engineering, cGMP cell banking, and regulatory support.
In 2015, Florida Biologix transitioned to a private entity with an investment from Ampersand Capital Partners and later merged with a Massachusetts-based biotechnology company to form Brammer Bio. This merger allowed the company to expand its offerings in viral vector process and analytical development, ultimately becoming part of Thermo Fisher Scientific's Viral Vector Services business in 2019.
Generated from the website
Also at this address
You might also like
Partial Data by Foursquare.